Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia

Indian Pediatrics

Volumn 33, Issue 7, 1996, Pages 556-560

  Raje, N S ^a   Vaidya, S J ^a   Kapoor, C ^a   Pai, S K ^a   Nair, C N ^a   Kurkute, P A ^a   Magrath, I T ^a   Advani, S H ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

cranial radiotherapy; leukemia; relapse

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; INCIDENCE; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RELAPSE; SKULL IRRADIATION;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIC INFILTRATION; MALE; METHOTREXATE;

EID: 0030055303     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Evans AE, Gilbert E, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970, 26: 404-409.
2. Aur R, Simone J, Hustu HO, Verzosa H. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphoblastic leukemia. Cancer 1972, 29: 381-391.
3. Bleyer WA, Poplack DG. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 1985, 12: 131-146.
4. Aur R, Simone J, Hustu HO, et al. Central nervous system therapy and combination chemotherapy of childhood lymphoblastic leukemia. Blood 1971, 37: 272-280.
5. Eden OB, Lilleyman JB, Richards S, Shaw MP, Peto J. Results of Medical Research Council Childhood leukemia trial UKALL VIII. Br J Hematol 1991, 78: 187-196.
6. Kreuger A, Garwicz S, Hertz H, Janmundsson G, Lanning M, Lie SO, et al. Central nervous system disease in childhood acute lymphoblastic leukemia. Prognostic factors and results of treatment. Pediatr Hematol Oncol 1991, 128: 291-299.
7. Rivera GK, Pui CH, Hancock ML, Mahmoud H, Santana V, Sandland JT, et al. Update of St. Jude Study XI for childhood acute lymphoblastic leukemia. Leukemia 1992, 6: 143-156.
8. Gelber RD, Sallan SE, Cohen HJ, Donnelly M, Dalton V, Tobia F, et al. CNS relapse in leukemias. Cancer 1993, 72: 261-270.
9. Pizzo PA, Poplack DG, Bleyer WA. Neurotoxicities of current leukemia therapy. Amer J Pediatr Hematol Oncol 1979, 1: 127-140.
10. Pavlovsky S, Castano J, Leiguard R. Neurophysiological study in patients with ALL. Amer J Pediatr Hematol Oncol 1983, 5: 79-86.
11. Kruena H, Stanhape R, Chessells JM, Leiper AD. Impaired pubertal growth in acute lymphoblastic leukemia. Arch Dis Child 1991, 66: 1403-1407.
12. Freeman AI, Weinberg V, Brecher ML, et al. Comparison of intermediate dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med 1983, 308: 477-484.
13. Buhrer C, Menze G, Hofman J. Central nervous system relapse prevention in 1165 standard risk children with acute lymphoblastic leukemia in five BFM trials. In: Acute Leukemia II. Ed. Buchner K. Berlin, Springer Verlag, 1990, pp 500-505.
14. Komp DM, Fernandez CH, Falletta JM, et al. CNS prophylaxis in ALL. Cancer 1982, 50: 1031-1036.